TERT promoter mutation in a primary lesion of papillary thyroid carcinoma predicts absent or lower 131I uptake in a metastatic lesion

被引：0
|
作者：
Meng, Zhaowei [1 ]
机构：
[1] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1527
引用
收藏
页数：2
相关论文
共 50 条
  • [11] False-Positive 131I Uptake After Transareola Endoscopic Thyroidectomy in a Patient With Papillary Thyroid Carcinoma
    Wang, Anbo
    Fu, Wenhui
    Deng, Ying
    He, Limeng
    Zhang, Wei
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (04) : 324 - 325
  • [12] Cytologic changes mimicking papillary carcinoma of the thyroid after 131I treatment
    Saqi, A
    Hoda, RS
    Kuhel, WI
    Vazquez, M
    Hoda, SA
    ACTA CYTOLOGICA, 1999, 43 (05) : 971 - 972
  • [13] 131I Accumulation Due to an Intrauterine Device in a Papillary Thyroid Carcinoma Patient
    Feng, Yuan
    Lan, Xiaoli
    Zhang, Xiao
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (04) : 341 - 342
  • [14] 131I accumulation in the inflammatory region of the lung in a woman with thyroid papillary carcinoma
    Fujimoto, Kanta
    Tahara, Yumiko
    Takahara, Shiho
    Iwakura, Toshio
    Matsuoka, Naoki
    Kobayashi, Hiromasa
    Hino, Megumu
    Ishihara, Takashi
    ENDOCRINE JOURNAL, 2010, 57 : S468 - S468
  • [15] False-Positive Uptake of 131I From Basal Cell Papilloma in a Patient With Metastatic Papillary Thyroid Cancer
    Luo, Lingling
    Wang, Jiaqiong
    Xia, Junyong
    Zhang, Ran
    Yao, Xiaobo
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : 358 - 360
  • [16] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Gerali, S
    Koutsikos, J
    Tsiouris, S
    Mainta, E
    Lucchetti, S
    Papathanasiou, G
    Fotinaki, E
    Makripoulias, V
    Kotsias, D
    Palestidis, C
    Zerva, C
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S425 - S425
  • [17] Diffuse Bone Uptake of 131I and Effect on Blood Counts in a Patient With Papillary Thyroid Carcinoma and Chronic Lymphocytic Leukemia
    Latge, Adrien
    Krim, Mehdi
    Vija, Lavinia
    Ysebaert, Loic
    Zerdoud, Slimane
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (04) : 340 - 341
  • [18] Iodine biokinetics and 131I absorbed dose in metastatic differentiated thyroid carcinoma
    Liu, Bin
    Kuang, Anren
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [19] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Zerva, C.
    Koutsikos, J.
    Palestidis, C.
    Kounadi, E.
    Gerali, S.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 50 (04): : 348 - 354
  • [20] Frontal lobe intracerebral schwannoma mimicking metastatic lesion in a patient with papillary thyroid carcinoma
    Sayyahmelli, Sima
    Kina, Hakan
    Ucer, Melih
    Salamat, M. Shahriar
    Baskaya, Mustafa K.
    JOURNAL OF SURGICAL CASE REPORTS, 2018, (08):
12345